Bank of America
LEGN icon

Bank of America’s Legend Biotech LEGN Stock Holding History

Bank of America’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.65M Buy
195,636
+17,774
+10% +$479K ﹤0.01% 3477
2026
Q1 		$3.22M Sell
177,862
-109,667
-38% -$2.09M ﹤0.01% 3784
2025
Q4 		$6.25M Sell
287,529
-74,030
-20% -$2.12M ﹤0.01% 3207
2025
Q3 		$11.8M Buy
361,559
+105,573
+41% +$3.9M ﹤0.01% 3141
2025
Q2 		$9.08M Buy
255,986
+87,707
+52% +$2.84M ﹤0.01% 3316
2025
Q1 		$5.71M Sell
168,279
-542,347
-76% -$19.5M ﹤0.01% 3674
2024
Q4 		$23.1M Buy
710,626
+467,386
+192% +$19.4M ﹤0.01% 2160
2024
Q3 		$11.9M Sell
243,240
-78,503
-24% -$4.18M ﹤0.01% 2909
2024
Q2 		$14.2M Sell
321,743
-87,810
-21% -$4.05M ﹤0.01% 2573
2024
Q1 		$23M Buy
409,553
+61,964
+18% +$3.74M ﹤0.01% 2141
2023
Q4 		$20.9M Buy
347,589
+76,225
+28% +$4.83M ﹤0.01% 2117
2023
Q3 		$18.2M Buy
271,364
+2,256
+0.8% +$157K ﹤0.01% 2123
2023
Q2 		$18.6M Sell
269,108
-185,776
-41% -$12.1M ﹤0.01% 2116
2023
Q1 		$21.9M Buy
454,884
+217,905
+92% +$10.7M ﹤0.01% 2031
2022
Q4 		$11.8M Sell
236,979
-157,226
-40% -$7.62M ﹤0.01% 2521
2022
Q3 		$16.1M Buy
394,205
+121,215
+44% +$5.69M ﹤0.01% 2151
2022
Q2 		$15M Buy
272,990
+12,995
+5% +$549K ﹤0.01% 2265
2022
Q1 		$9.45M Buy
259,995
+162,642
+167% +$6.43M ﹤0.01% 2923
2021
Q4 		$4.54M Buy
97,353
+93,071
+2,174% +$4.72M ﹤0.01% 3757
2021
Q3 		$217K Sell
4,282
-9,842
-70% -$410K ﹤0.01% 6250
2021
Q2 		$579K Buy
14,124
+3,970
+39% +$135K ﹤0.01% 5304
2021
Q1 		$295K Buy
10,154
+10,099
+18,362% +$275K ﹤0.01% 5760
2020
Q4 		$2K Hold
55
– – ﹤0.01% 6943
2020
Q3 		$2K Buy
+55
New +$1.85K ﹤0.01% 6698

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Bank of America's LEGN Position: Q2 2026 in Review

Bank of America increased its Legend Biotech (LEGN) stake by 10% in Q2 2026, buying an estimated $479K and bringing the position to 195,636 shares worth $5.65M. The position accounts for ﹤0.01% of the portfolio, ranked #3477.

Bank of America first reported a position in LEGN in Q3 2020 and has held it in 24 quarters since. The position peaked at $23.1M in Q4 2024. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Bank of America held 195,636 shares of Legend Biotech worth $5.65M as of Q2 2026.
  • Bank of America bought 17,774 Legend Biotech shares in Q2 2026, an estimated $479K.
  • Legend Biotech made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #3477 holding.
  • Bank of America first reported a position in Legend Biotech in Q3 2020 and has held it in 24 quarters since.
  • Bank of America's Legend Biotech position peaked at $23.1M in Q4 2024.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.